JP2020536489A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536489A5 JP2020536489A5 JP2020508007A JP2020508007A JP2020536489A5 JP 2020536489 A5 JP2020536489 A5 JP 2020536489A5 JP 2020508007 A JP2020508007 A JP 2020508007A JP 2020508007 A JP2020508007 A JP 2020508007A JP 2020536489 A5 JP2020536489 A5 JP 2020536489A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- conserved
- seq
- sequences
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 46
- 108020004707 nucleic acids Proteins 0.000 claims 29
- 102000039446 nucleic acids Human genes 0.000 claims 29
- 150000007523 nucleic acids Chemical class 0.000 claims 29
- 229920001184 polypeptide Polymers 0.000 claims 27
- 102000004196 processed proteins & peptides Human genes 0.000 claims 27
- 238000002255 vaccination Methods 0.000 claims 9
- 239000002671 adjuvant Substances 0.000 claims 8
- 239000013603 viral vector Substances 0.000 claims 7
- 229960005486 vaccine Drugs 0.000 claims 5
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 230000000638 stimulation Effects 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 2
- 238000002649 immunization Methods 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000037452 priming Effects 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 208000009608 Papillomavirus Infections Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 108091036078 conserved sequence Proteins 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000013600 plasmid vector Substances 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1713163.2A GB201713163D0 (en) | 2017-08-16 | 2017-08-16 | HPV vaccine |
| GB1713163.2 | 2017-08-16 | ||
| PCT/GB2018/052335 WO2019034887A1 (en) | 2017-08-16 | 2018-08-16 | HPV VACCINE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020536489A JP2020536489A (ja) | 2020-12-17 |
| JP2020536489A5 true JP2020536489A5 (enExample) | 2021-09-30 |
| JP7551495B2 JP7551495B2 (ja) | 2024-09-17 |
Family
ID=59895974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020508007A Active JP7551495B2 (ja) | 2017-08-16 | 2018-08-16 | Ｈｐｖワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11179456B2 (enExample) |
| EP (1) | EP3668542A1 (enExample) |
| JP (1) | JP7551495B2 (enExample) |
| KR (1) | KR102713224B1 (enExample) |
| CN (1) | CN111212659B (enExample) |
| AU (1) | AU2018316734B2 (enExample) |
| CA (1) | CA3072536A1 (enExample) |
| GB (1) | GB201713163D0 (enExample) |
| MX (1) | MX2020001655A (enExample) |
| SG (1) | SG11202001244SA (enExample) |
| WO (1) | WO2019034887A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201713163D0 (en) | 2017-08-16 | 2017-09-27 | Univ Oxford Innovation Ltd | HPV vaccine |
| TWI852977B (zh) * | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| MX2022004484A (es) * | 2019-10-16 | 2022-07-19 | Cancer Research Tech Ltd | Vector para el tratamiento de cancer. |
| EP4175664A2 (en) | 2020-07-06 | 2023-05-10 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| WO2022009049A1 (en) | 2020-07-06 | 2022-01-13 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| GB202019767D0 (en) | 2020-12-15 | 2021-01-27 | Chain Biotechnology Ltd | Compostitions and methods |
| GB202209115D0 (en) | 2022-06-21 | 2022-08-10 | Chain Biotechnology Ltd | Compositions and methods |
| WO2024218165A1 (en) * | 2023-04-17 | 2024-10-24 | Barinthus Biotherapeutics (Uk) Limited | Hpv viral vector vaccine |
| WO2025092908A1 (zh) * | 2023-11-01 | 2025-05-08 | 仁景(苏州)生物科技有限公司 | 治疗HPV感染相关疾病的mRNA疫苗 |
| CN119464385B (zh) * | 2024-12-04 | 2026-04-07 | 华中科技大学同济医学院附属同济医院 | Matv11重组腺病毒载体、应用、制备方法及hpv治疗性疫苗 |
| CN121950873A (zh) * | 2026-01-28 | 2026-05-01 | 广东药科大学 | 一种融合基因及hpv核酸疫苗 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026443B1 (en) | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
| EP1732598A4 (en) * | 2003-12-31 | 2009-08-26 | Pharmexa Inc | TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| CN113559253B (zh) * | 2007-11-02 | 2024-09-17 | 约翰霍普金斯大学 | 用于治疗或预防人乳头瘤病毒感染的多型hpv肽的组合物和方法 |
| ES2464451T3 (es) | 2008-02-21 | 2014-06-02 | Delphi International Operations Luxembourg S.À R.L. | Inyector de fuel con una disposición de control de válvula mejorada |
| CN102498217A (zh) | 2009-04-20 | 2012-06-13 | 阿波维塔公司 | Hpv的e6蛋白的特异性抗体及其应用 |
| WO2014103608A1 (ja) | 2012-12-25 | 2014-07-03 | 一般財団法人化学及血清療法研究所 | HPV/HBsキメラタンパク質を有効成分とするHPV感染症及び／又はＢ型肝炎用ワクチン |
| WO2014165291A1 (en) | 2013-03-12 | 2014-10-09 | The Trustees Of The University Of Pennsylvania | Improved vaccines for human papilloma virus and methods for using the same |
| WO2018060288A1 (en) | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| GB201713163D0 (en) | 2017-08-16 | 2017-09-27 | Univ Oxford Innovation Ltd | HPV vaccine |
-
2017
- 2017-08-16 GB GBGB1713163.2A patent/GB201713163D0/en not_active Ceased
-
2018
- 2018-08-16 AU AU2018316734A patent/AU2018316734B2/en not_active Expired - Fee Related
- 2018-08-16 JP JP2020508007A patent/JP7551495B2/ja active Active
- 2018-08-16 WO PCT/GB2018/052335 patent/WO2019034887A1/en not_active Ceased
- 2018-08-16 MX MX2020001655A patent/MX2020001655A/es unknown
- 2018-08-16 CN CN201880053063.XA patent/CN111212659B/zh active Active
- 2018-08-16 US US16/639,144 patent/US11179456B2/en active Active
- 2018-08-16 SG SG11202001244SA patent/SG11202001244SA/en unknown
- 2018-08-16 CA CA3072536A patent/CA3072536A1/en active Pending
- 2018-08-16 KR KR1020207006062A patent/KR102713224B1/ko active Active
- 2018-08-16 EP EP18759700.0A patent/EP3668542A1/en not_active Withdrawn
-
2021
- 2021-11-22 US US17/532,177 patent/US12064477B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3036962T3 (en) | Hbv vaccine | |
| JP2025184979A5 (enExample) | ||
| US7569228B2 (en) | Fusion proteins of non-attenuated HIV regulatory/accessory proteins | |
| JP2020516264A5 (enExample) | ||
| JP2016146837A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2009544333A5 (enExample) | ||
| JP2017522907A5 (enExample) | ||
| JP2013501038A5 (enExample) | ||
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| CA2617341A1 (en) | Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus | |
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| US7998484B2 (en) | Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines | |
| JP2003510050A5 (enExample) | ||
| JP2023522154A5 (enExample) | ||
| JP2018533908A5 (enExample) | ||
| CN114269939B (zh) | 汉坦病毒抗原组合物 | |
| JP2023510544A5 (enExample) | ||
| RU2019113940A (ru) | Мозаичные вакцины от вируса ящура серотипа а | |
| US20060204514A1 (en) | Expression of hydrophobic proteins | |
| US11154613B2 (en) | HCV vaccines | |
| JP2024543954A5 (enExample) | ||
| TH51753A (th) | cDNA โคลน ที่ทำให้ติดเชื้อได้ของไวรัสกลุ่มอาการโรคเกี่ยวกับการสืบพันธ์และการหายใจของสุกร (PRRS) สายพันธ์อเมริกาเหนือ และการใช้ cDNA โคลนนี้ | |
| NZ747030B2 (en) | Fmdv recombinant vaccines and uses thereof |